• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沉默信息调节因子 6 作为骨再生和修复潜在治疗靶点的研究进展。

Research advances on silence information regulator 6 as a potential therapeutic target for bone regeneration and repair.

机构信息

Department of Orthopedics, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.

出版信息

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Aug 25;53(4):427-433. doi: 10.3724/zdxbyxb-2023-0615.

DOI:10.3724/zdxbyxb-2023-0615
PMID:39183069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11375492/
Abstract

Segmental bone defects and nonunion of fractures caused by trauma, infection, tumor or systemic diseases with limited osteogenesis and prolonged bone healing cycles are challenging issues in orthopedic clinical practice. Therefore, identifying regulatory factors for bone tissue regeneration and metabolism is crucial for accelerating bone repair and reconstructing defective areas. Silence information regulator 6 (SIRT6), functioning as a deacetylase and nucleotide transferase, is extensively involved in the regulation of differentiation, apoptosis, metabolism, and inflammation in bone cells including osteoblasts and osteoclasts, and is considered to be an important factor in regulating bone metabolism. SIRT6 forms a complex with B lymphocyte-induced maturation protein 1 (Blimp1), down-regulates the expression of the nuclear factor κB (NF-κB) pathway, and promotes the expression of the ERα-FasL axis signal to inhibit osteoclast formation and maturation differentiation, thereby hindering bone resorption and increasing bone mass. In addition, SIRT6 activates the Akt-mTOR pathway to regulate the autophagy level and osteogenesis of bone marrow mesenchymal stem cells, inhibits glycolysis and reactive oxygen production in osteoblasts, promotes osteoblast differentiation through the CREB/CCN1/COX2 pathway and the bone morphogenetic protein (BMP) signaling pathway, enhances bone formation, and accelerates bone regeneration and repair of skeletal tissue. This article provides an overview of the research progress on SIRT6 in the pathophysiology of bone regeneration, revealing its potential as a novel therapeutic target for bone tissue repair to alleviate the progression of skeletal pathological diseases.

摘要

节段性骨缺损和骨折不愈合是创伤、感染、肿瘤或全身性疾病引起的,这些疾病的成骨有限,骨愈合周期延长,是骨科临床实践中的难题。因此,确定骨组织再生和代谢的调节因子对于加速骨修复和重建缺损区域至关重要。沉默信息调节因子 6(SIRT6)作为一种去乙酰化酶和核苷酸转移酶,广泛参与成骨细胞和破骨细胞分化、凋亡、代谢和炎症的调节,被认为是调节骨代谢的重要因素。SIRT6 与 B 淋巴细胞诱导成熟蛋白 1(Blimp1)形成复合物,下调核因子 κB(NF-κB)通路的表达,促进 ERα-FasL 轴信号的表达,抑制破骨细胞的形成和成熟分化,从而抑制骨吸收,增加骨量。此外,SIRT6 激活 Akt-mTOR 通路来调节骨髓间充质干细胞的自噬水平和成骨作用,抑制成骨细胞中的糖酵解和活性氧的产生,通过 CREB/CCN1/COX2 通路和骨形态发生蛋白(BMP)信号通路促进成骨细胞分化,增强骨形成,加速骨骼组织的再生和修复。本文综述了 SIRT6 在骨再生病理生理学中的研究进展,揭示了其作为骨组织修复的新型治疗靶点的潜力,以缓解骨骼病理疾病的进展。

相似文献

1
Research advances on silence information regulator 6 as a potential therapeutic target for bone regeneration and repair.沉默信息调节因子 6 作为骨再生和修复潜在治疗靶点的研究进展。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Aug 25;53(4):427-433. doi: 10.3724/zdxbyxb-2023-0615.
2
SIRT6 regulates osteogenic differentiation of rat bone marrow mesenchymal stem cells partially via suppressing the nuclear factor-κB signaling pathway.沉默调节蛋白6(SIRT6)部分通过抑制核因子κB信号通路来调控大鼠骨髓间充质干细胞的成骨分化。
Stem Cells. 2014 Jul;32(7):1943-55. doi: 10.1002/stem.1671.
3
Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts.补骨脂素通过激活破骨细胞和成骨细胞来加速骨折愈合。
FASEB J. 2019 Apr;33(4):5399-5410. doi: 10.1096/fj.201801797R. Epub 2019 Jan 31.
4
Loss of Sirtuin 6 in osteoblast lineage cells activates osteoclasts, resulting in osteopenia.成骨细胞谱系细胞中 Sirtuin 6 的缺失会激活破骨细胞,导致骨质疏松症。
Bone. 2020 Sep;138:115497. doi: 10.1016/j.bone.2020.115497. Epub 2020 Jun 27.
5
Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway.肝细胞生长因子通过骨形态发生蛋白-2 介导的 NF-κB 信号通路促进骨再生。
Mol Med Rep. 2018 Apr;17(4):6045-6053. doi: 10.3892/mmr.2018.8559. Epub 2018 Feb 6.
6
Osteogenic differentiation of rat bone mesenchymal stem cells modulated by MiR-186 via SIRT6.miR-186 通过 SIRT6 调节大鼠骨髓间充质干细胞的成骨分化。
Life Sci. 2020 Jul 15;253:117660. doi: 10.1016/j.lfs.2020.117660. Epub 2020 Apr 12.
7
DZNep promotes mouse bone defect healing via enhancing both osteogenesis and osteoclastogenesis.DZNep 通过增强成骨和破骨作用促进小鼠骨缺损愈合。
Stem Cell Res Ther. 2021 Dec 20;12(1):605. doi: 10.1186/s13287-021-02670-6.
8
Phenotypic research on senile osteoporosis caused by SIRT6 deficiency.SIRT6缺乏所致老年骨质疏松症的表型研究
Int J Oral Sci. 2016 Jun 30;8(2):84-92. doi: 10.1038/ijos.2015.57.
9
Sirt6 cooperates with Blimp1 to positively regulate osteoclast differentiation.Sirt6与Blimp1协同作用,正向调节破骨细胞分化。
Sci Rep. 2016 May 18;6:26186. doi: 10.1038/srep26186.
10
Pilose antler peptide potentiates osteoblast differentiation and inhibits osteoclastogenesis via manipulating the NF-κB pathway.鹿茸多肽通过调控核因子κB信号通路促进成骨细胞分化并抑制破骨细胞生成。
Biochem Biophys Res Commun. 2017 Sep 16;491(2):388-395. doi: 10.1016/j.bbrc.2017.07.091. Epub 2017 Jul 18.

引用本文的文献

1
New Perspectives on Postmenopausal Osteoporosis: Mechanisms and Potential Therapeutic Strategies of Sirtuins and Oxidative Stress.绝经后骨质疏松症的新视角:沉默调节蛋白与氧化应激的机制及潜在治疗策略
Antioxidants (Basel). 2025 May 17;14(5):605. doi: 10.3390/antiox14050605.

本文引用的文献

1
Sirtuins mediate mitochondrial quality control mechanisms: a novel therapeutic target for osteoporosis.Sirtuins 介导线粒体质量控制机制:骨质疏松症的一个新的治疗靶点。
Front Endocrinol (Lausanne). 2024 Jan 8;14:1281213. doi: 10.3389/fendo.2023.1281213. eCollection 2023.
2
Sirtuin 6 ameliorates arthritis through modulating cyclic AMP-responsive element binding protein/CCN1/cyclooxygenase 2 pathway in osteoblasts.Sirtuin 6 通过调节成骨细胞中环腺苷酸反应元件结合蛋白/CCN1/环氧合酶 2 通路改善关节炎。
J Bone Miner Metab. 2023 Nov;41(6):772-784. doi: 10.1007/s00774-023-01468-1. Epub 2023 Oct 29.
3
Modulation of SIRT6 activity acts as an emerging therapeutic implication for pathological disorders in the skeletal system.SIRT6活性的调节作为骨骼系统病理紊乱的一种新兴治疗手段。
Genes Dis. 2022 Feb 12;10(3):864-876. doi: 10.1016/j.gendis.2021.12.024. eCollection 2023 May.
4
Sirtuin 6 inhibition protects against glucocorticoid-induced skeletal muscle atrophy by regulating IGF/PI3K/AKT signaling.Sirtuin 6 抑制通过调节 IGF/PI3K/AKT 信号通路保护糖皮质激素诱导的骨骼肌萎缩。
Nat Commun. 2022 Sep 15;13(1):5415. doi: 10.1038/s41467-022-32905-w.
5
Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth.AKT 抑制诱导 p53/SIRT6/PARP1 依赖性 parthanatos 抑制肿瘤生长。
Cell Commun Signal. 2022 Jun 17;20(1):93. doi: 10.1186/s12964-022-00897-1.
6
Combining Mg-Zn-Ca Bulk Metallic Glass with a Mesoporous Silica Nanocomposite for Bone Tissue Engineering.将镁锌钙块体金属玻璃与介孔二氧化硅纳米复合材料结合用于骨组织工程。
Pharmaceutics. 2022 May 17;14(5):1078. doi: 10.3390/pharmaceutics14051078.
7
Myokine Irisin promotes osteogenesis by activating BMP/SMAD signaling via αV integrin and regulates bone mass in mice.肌肉因子鸢尾素通过αV 整联蛋白激活 BMP/SMAD 信号通路促进成骨作用,并调节小鼠的骨量。
Int J Biol Sci. 2022 Jan 1;18(2):572-584. doi: 10.7150/ijbs.63505. eCollection 2022.
8
Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.通过 Hsp90ab1/肌球蛋白结合蛋白介导的 TGFβ/FN1/CD44 信号抑制,利用成骨细胞蛋白质组抑制乳腺癌相关性骨丢失。
Theranostics. 2022 Jan 1;12(2):929-943. doi: 10.7150/thno.66148. eCollection 2022.
9
Hypothalamic Actions of SIRT1 and SIRT6 on Energy Balance.SIRT1 和 SIRT6 对能量平衡的下丘脑作用。
Int J Mol Sci. 2021 Jan 31;22(3):1430. doi: 10.3390/ijms22031430.
10
Role of sirtuins in bone biology: Potential implications for novel therapeutic strategies for osteoporosis.沉默调节蛋白在骨生物学中的作用:对骨质疏松症新型治疗策略的潜在影响。
Aging Cell. 2021 Feb;20(2):e13301. doi: 10.1111/acel.13301. Epub 2021 Jan 4.